av0113 dendritic cell cancer immune therapy
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2000 (NCT02533895)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- av0113 dendritic cell cancer immune therapy
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02533895 | Phase 1 | Feb 1, 2000 | AOP Orphan Pharmaceuticals AG, Medical University of Vienna |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AOP Orphan Pharmaceuticals AG | For profit | 1 | 1 | 1 | 2000 |
| Medical University of Vienna | Academic/Hospital | 1 | 0 | 1 | 2000 |
2 organizations
Page 1 / 1